MedTrace Logo

Prestige Pilot - Phoenix Atherectomy and Stellarex DCB Clinical Investigation in Infrapopliteal Interventions

NCT03744572 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 56

Last updated 2023-01-26

No results posted yet for this study

Summary

This pilot study is to investigate if a lesion preparation strategy with Phoenix atherectomy before DCB (drug coated balloon) usage in patients with PAD (peripheral artery disease) Rutherford Stage 4-5 and mild/moderate/severe calcium can improve outcomes including patency and limb salvage and evaluate safety and performance of the combination therapy

Conditions

  • Peripheral Artery Disease (PAD)

Sponsors & Collaborators

  • Michael Lichtenberg, MD

    lead OTHER

Principal Investigators

  • Michael Lichtenberg, Dr. · Vascular Center, Klinikum Hochsauerland GmbH

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-17
Primary Completion
2020-12-22
Completion
2022-06-01

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03744572 on ClinicalTrials.gov